Showing 1,659 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

US FDA panel backs Merck hepatitis drug

Editor's pick
Reuters
28 April 2011
New & experimental hepatitis C treatment

Some Biotechs May Benefit From Hepatitis C Treatment Market Shift

Editor's pick
Seeking Alpha
27 April 2011
Hepatitis C transmission & prevention

Severity of hepatitis C and HIV co-infection in mothers contribute to HCV transmission to child

Editor's pick
Eurekalert HIV
27 April 2011
New & experimental hepatitis C treatment

Merck- Boceprevir, Vertex-Telaprevir Prep for Hep C Drug Panels

Editor's pick
The Street
21 April 2011
New & experimental hepatitis C treatment

European Gastroenterologists Will Prescribe Telaprevir and Boceprevir to Nonresponder and Treatment-Naive Patients Following Launch, Leading to Higher Treatment Costs Than Interviewed Payers Expect

Editor's pick
Business Wire
19 April 2011
Pharmaceutical industry

Hepatitis C: Greenwich doctor accused of insider trading

Editor's pick
HCV New Drugs Research
14 April 2011
Hepatitis B

HBV Genotype Predicts HBeAg Seroconversion on Tenofovir

Editor's pick
HIVandhepatitis.com
14 April 2011
Hepatitis B

Immune-Based Therapy GS-9620 Shows Promise for Hepatitis B

Editor's pick
HIVandhepatitis.com
14 April 2011
Hepatitis C treatment

New Analysis Finds Antidepressants Boost Patient Adherence to Hepatitis C Treatment

Editor's pick
PR Newswire
12 April 2011
Hepatitis C symptoms & diagnosis

Tackling hepatitis C: a tale of two countries

Editor's pick
The Lancet
11 April 2011
Exposure to HIV through medical procedures

A New Push to Let HIV Patients Accept Organs That Are Infected

Editor's pick
11 April 2011
Exposure to HIV through medical procedures

A New Push to Let HIV Patients Accept Organs That Are Infected

Editor's pick
New York Times
11 April 2011
New & experimental hepatitis C treatment

Pegylated Interferon Lambda Boosts Response with Few Side Effects

Editor's pick
HIVandhepatitis.com
5 April 2011
New & experimental hepatitis C treatment

Telaprevir Improves HCV Cure Rates Regardless of IL28B Status

Editor's pick
HIVandhepatitis.com
5 April 2011
New & experimental hepatitis C treatment

First Sustained Response Data for Polymerase Inhibitor Mericitabine

Editor's pick
HIVandhepatitis.com
5 April 2011
New & experimental hepatitis C treatment

Polymerase Inhibitor PSI-7977 Works with Interferon or Companion Drug

Editor's pick
HIVandhepatitis.com
5 April 2011
New & experimental hepatitis C treatment

Avalanche of hepatitis C products on the way

Editor's pick
Pharma Times
4 April 2011
New & experimental hepatitis C treatment

Bristol-Myers Interferon-Free Combo Cured Hepatitis Patients

Editor's pick
Bloomberg
4 April 2011
New & experimental hepatitis C treatment

Merck, J&J’s New Hepatitis C Treatments Fetch $31,000 in France

Editor's pick
Bloomberg
4 April 2011
New & experimental hepatitis C treatment

Idera Pharmaceuticals Presents Data from a Phase 1 Clinical Trial of IMO-2125 in Treatment-Naïve Genotype 1 HCV Patients at EASL 2011

Editor's pick
Business Wire
4 April 2011
New & experimental hepatitis C treatment

Quadruple therapy shows 100 percent SVR for HCV patients previously unresponsive to treatment

Editor's pick
Eurekalert HIV
2 April 2011
Hepatitis C transmission & prevention

First vaccine for viral hepatitis C could become a reality

Editor's pick
Eurekalert Inf Dis
1 April 2011
New & experimental hepatitis C treatment

Inhibitex Reports Positive Safety and Antiviral Data from Its Phase 1b Study of HCV Nucleotide Inhibitor INX-189

Editor's pick
Pipeline Review
1 April 2011
New & experimental hepatitis C treatment

'Fantastic' data on Novartis' first-in-class hep C antiviral

Editor's pick
Pharma Times
1 April 2011